Atlanta-area independent community pharmacist Jonathan Marquess, PharmD, CDE, CPT briefed Congressional staffers June 6 regarding how medication therapy management (MTM) and other pharmacist services can help patients achieve better outcomes while reducing overall health care costs.
Archive for the 'DME' Category
Community Pharmacist Briefs Capitol Hill on Medication Therapy Management, Pharmacist Provider StatusPublished June 7, 2013 DME , MTM Leave a Comment
Tags: durable medical equipment, medication therapy management
Tags: durable medical equipment
Most independent community pharmacies provide durable medical equipment (DME), like diabetes testing supplies, to meet essential health needs while partially offsetting diminishing prescription drug reimbursement. About one out of every three pharmacies that offer these test kits also stock therapeutic shoes for diabetics and these pharmacies may soon face more demanding audits by Medicare contractors.
For years, the Centers for Medicare & Medicaid Services (CMS) appeared to consider a signed certifying statement by a physician as sufficient evidence to support a claim for reimbursement for therapeutic shoes.
More recently, NCPA members noticed that Medicare Administrative Contractors (MACs) seemingly altered their auditing practices and began to seek recoupment of reimbursements, even in instances in which the supplier produced a signed certifying physician statement. Instead the MACs began demanding that the pharmacy produce medical records from the physician to match the information on the certifying statement or written order.
NCPA is asking CMS to reevaluate this situation, which has the potential to undermine patient access to these products as pharmacies choose to stop offering them because of the burdensome auditing requirements that they now face.
What follows are excerpts from a letter NCPA sent to the agency:
“Requiring suppliers, such as independent community pharmacies, to obtain medical records from physicians imposes a significant administrative burden on small business suppliers, as well as physicians. Physicians now want to know why their signature on the certifying statement is no longer sufficient and are resistant to the extra effort required to meet supplier requests for physician records. Given the administrative burdens, these physicians may be reticent to provide future referrals to the suppliers.
“Presently, some suppliers have indicated that the new administrative burden is too much for them and that they may decide to stop providing therapeutic shoes. As a result, patients are either forced to obtain their therapeutic shoes from other suppliers, or simply refrain from obtaining the shoes. In the latter situation, in the end, all too often these fragile, high risk patients go from needing therapeutic shoes to developing even more serious lower extremity complications.
“The bottom line is that suppliers are put in the untenable position of being asked to provide care without knowing whether the physician’s records provide adequate documentation or whether the supplier will be able to obtain those records. … We urge CMS to revert to its original enforcement policy of accepting the signed and dated certifying statement as sufficient documentation for the provision of therapeutic shoes and inserts. Without this change in policy, many suppliers will cease to provide therapeutic shoes, patients will lose access to those necessary medical supplies and patient diabetic health outcomes will suffer.”
Tags: durable medical equipment
Since its creation in 1992, the 340B discount prescription drug program has continued to expand and provisions in the new health care reform law, as well as a “tax extenders” bill pending in Congress, will grow the 340B program’s reach further still. What does it mean for independent community pharmacies?
Tags: durable medical equipment
Community pharmacists on the front lines can be very powerful advocates for their profession and their patients by offering first-hand account. For example, a Montana pharmacist recently wrote what could be considered a model letter to U.S. Senator Jon Tester (D-Mont.), articulately making the case for Congress to act to allow small pharmacies to continue providing diabetes testing supplies to seniors.
Community pharmacists held over 200 meetings with Members of Congress and their staffs in Washington this month and, during the Memorial Day recess next week, pharmacists are playing the hosts and opening their doors to lawmakers.
Tags: adherence, Health Care Reform, Medicaid, pharmacist
Health care reform included several provisions to help community pharmacists help their patients, but pharmacists are in no position to sit on the sidelines now that the bill has become law, Bruce T. Roberts, RPh, said in his final address to NCPA’s Legislation and Government Affairs Conference this week. Continue reading ‘Roberts: Progress Made; More Battles Ahead; and Adherence is Critical’
Tags: average manufacturer price, durable medical equipment, pharmacy benefit managers
By John Norton
(NOTE: To read all NCPA opinion pieces go to the following link.)
As the health care reform efforts kicks into overdrive, NCPA recently had three opinion pieces published advocating for patients and community pharmacies on three major issues: mandatory mail order; durable medical equipment (DME) accreditation; and Medicaid’s Average Manufacturer Price (AMP) based cuts.
Tags: average manufacturer price, Health Care Reform, Medicare, medication therapy management, pharmacist, pharmacy benefit managers
We’re still reviewing the 2,000+ page health reform proposal released by Senate Democratic leaders Wednesday night, but here’s what our initial read shows:
Tags: durable medical equipment, immunization, medication therapy management, pharmacist
“Be willing to venture outside of your comfort zone,” ABC’s Robin Roberts advised during her recent speech to NCPA convention-goers. “Expand your business. Offer new services.”
Tags: Health Care Reform, pharmacist
For an insightful and succinct look at the issues facing community pharmacy today, check out the interview our friends at Drug Topics recently did with Jon Copeland and Bruce Semingson, two longtime NCPA allies and staunch supporters of independent community pharmacy. Mr. Copeland and Mr. Semingson are, respectively, CEO and COO of American Associated Pharmacies, an influential buying group cooperative.